Catecholamineinduced cardiomyopathy in patients with pheochromocytoma

Cover Page


The article discusses the reasons of specific cardiomyopathy in patients with pheochromocytoma and post operation lungs oedema. 106 pheochromocytoma patients were operated between 2004 and 2012 in Endocrine Research Center, 19 of them were investigated for ischemia myocardial changes. This cohort is divided into 2 groups: the first one includes 13 patients with preoperation notes of acute myocardial infarc tion (non Q developing), the second one consists of 6 patients with lung oedema in early postoperation time. All patients were operated after adequate preparation with α and βblockers. After clinical examina tion only 1 patient had conclusive ischemia, which required correction. Among reasons influencing a lung oedema (tumour size, manipulation time, age, sex, fluctuations of blood pressure) only the epinephrine type of tumor secretion was significant. Conclusion. Patients with adrenaline type secretion of pheochromocytoma have a higher risk of a lung oedema. The level of risk doesn’t depend on myocardial ischemia. Discussion. Possibility and necessity of administration of tyrozinkynase inhibitor (αmetylparatyrozine) or sensitisers of myocardial contraction (levosemindan) as the main means for preparation to a pheochromo cytoma surgery in epinephrinetype patients must be considered.

About the authors

D G Beltsevich

doktor med. nauk, glavnyy nauchnyy sotrudnik FGBU ENTs

A B Kuznetsov

kand. med. nauk, vrach otdeleniya invazivnoy kardiologii FGBU ENTs

M A Lysenko

kand. med. nauk, vrach otdeleniya neyroendokrino logii FGBU ENTs

L E Kats

kand. med. nauk, zaveduyushchaya otdeleniem anesteziologii i reanimatsii FGBU ENTs

I S Gomgjin

M Yu Yukina

kand. med. nauk, nauchnyy sotrudnik otdeleniya terapii FGBU ENTs


  1. Priest W.M. Phaeochromocytoma with fatal myocardial infarction in a managed 22. BMJ. 1952; 860–861.
  2. Northfield T.C. Cardiac complications of pheochromocytoma. Brit. Heart J. 1967; 29: 5-88.
  3. Cohen C.D., Dent D.M. Phaeochromocytoma and acute cardiovascular death (with special reference to myocardial infarction). Postgraduate Med. J. 1984; 60: 111–115.
  4. Lebedevskaia V.P. Pathomorphological changes in the heart and its vessels in adrenal pheochromocytoma. Arkh. Patol. 1981; 43 (9): 26–30.
  5. Zelinka T., Petrak O., Turkova H., Holaj R. High incidence of cardiovascular complications in pheochromocytoma. Horm. Metab Res. 2012; 44 (5): 379–384.
  6. Kassim T.A., Clarke D.D., Mai V.Q. et al. Catecholamine induced cardiomyopathy. Endocrinol. Pract. 2008; 14 (9): 1137–1149.
  7. Liao W.B., Liu C.F., HingWen Chiang H.W. Cardiovascular manifestations of pheochromocytoma. Am. J. of Emer. Med. 2000; 5: 622–625.
  8. Hass G.J., Tzagournis M., Boudoulas H. Pheochromocytoma: catecholamine-mediated electrocardiographic changes mimicking ischemia. Am. Heart J. 1988; 116: 1363–1365.
  9. Van Braeckel P., Carlier S., Steelant P.J. et al. Perioperative management of phaeochromocytoma. Acta Anaesthesiol Belg. 2009; 60 (1): 55–66.
  10. Gianni M., Dentali F., Grandi A.M. et al. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur. Heart J. 2006; 27: 1523–1529.
  11. Paur H., Wright P.T., Sikkel M.B., Tranter M.H. High levels of circulating epinephrine trigger apical cardiodepression in a β2adrenergic receptor/Gidependent manner: a new model of takotsubo cardiomyopathy. Circulation. 2012; 126 (6): 697–706.
  12. Agarwal V., Kant G., Hans N., Messerli F.H. Takotsubolike cardiomyopathy in pheochromocytoma. Int. J. Cardiol. 2011; 153 (3): 241–248.
  13. Koeth O., Mark B., Cornelius B. et al. Cardiogenic shock after adrenalectomy for pheochromocytoma. Internist (Berl.). 2007; 48 (2): 189–193.
  14. Leaver S.K., Evans T.W. Acute respiratory distress syndrome. BMJ. 2007; 335: 389–394.
  15. Blom H.J., Karsdorp V., Birnie R., Davies G. Phaeochromo cytoma as a cause of pulmonary oedema. Anaesthesia. 1987; 42 (6): 646–650.
  16. Coppens F., Tsicopoulos A., Marquette C.H. et al. Pheo chromocytoma revealed by pulmonary edema. Rev. Mal. Respir. 1989; 6 (5): 457–459.
  17. Ford J., Rosenberg F., Chan N. Pheochromocytoma mani festing with shock presents a clinical paradox: a case report. Can. Med. Assoc. J. 1997; 157: 923–925.
  18. Mok C.C., Ip T.P., So C.C. Phaeochromocytoma with adult respiratory distress syndrome mimicking septicaemic shock. Med. J. Aust. 1997; 166 (12): 634–635.
  19. Naeije R., Yernault J.C., Goldstein M., Corhil A. Acute pulmonary oedema in a patient with phaeochromocytoma. Intensive Care Med. 1978; 4 (3): 165–167.
  20. O'Hikeys S., Hilton A.M., Whittaker J.S. Phaeochromocytoma associated with adult respiratory distress syndrome. Thorax. 1987; 42: 157–158.
  21. Peter W., Jacob B.G., Engelhardt D., Decker W. Anusual cause of acute lung edema requiring artificial respiration in a 25-year-old patient. Adrenal pheochromocytoma. Internist (Berl.). 2002; 43 (10): 1285–1288.
  22. 22. Porzig A., Matthay K.K., Dubois S. et al. Proteinuria in metastatic pheochromocytoma is associated with an increased risk of Acute Respiratory Distress Syndrome, spontaneously or after therapy with 131I-metaiodobenzylguanidine 131IMIBG). Horm. Metab. Res. 2012; 44 (7): 539–542. doi: 10.1055/s00321311634.
  23. Van der Kleij F.G. Adult respiratory distress syndrome due to pheochromocytoma as the initial presentation of multiple endocrine neoplasia type IIA syndrome. Am. J. Med. 1999; 107 (4): 401.
  24. Malhotra S.K., Ramprabu K., Dutta A., Behera A. An unusual cause of respiratory distress and hypotension following removal of a pheochromocytoma. Can. J. Anaesth. 2002; 49 (10): 1099–1100.
  25. Touboul J.L., Sicard J.F., Cresson E., Michel F. Acute noncardiogenic pulmonary edema during resection of a bladder paraganglioma (pheochromocytoma). Rev. Pneumol. Clin. 1985; 41 (3): 197–199.
  26. Theodore J., Robin E.D. Pathogenesis of neurogenic pulmonary oedema. Lancet. 1975; 2 (7938): 749–751.
  27. Theodore J., Robin E.D. Speculations on neurogenic pulmonary edema (NPE). Am. Rev. Respir. Dis. 1976; 113 (4): 405–411.
  28. Malik A.B. Mechanisms of neurogenic pulmonary edema. Circ. Res. 1985; 57: 1–18.
  29. Perry R.R. Surgical management of pheochromocytoma with the use of metyrosine. Ann. Surg. 1990. 212 (5): 621–628.
  30. Sand J., Salmi J., Saaristo J., Auvinen O. Preoperative treat ment and survival of patients with pheochromocytomas. Ann. Chir. Gynaecol. 1997; 86 (3): 230–232.
  31. Steinsapir J., Carr A.A., Prisant L.M., Bransome E.D. Jr. Metyrosine and pheochromocytoma. Arch. Intern. Med. 1997; 157 (8): 901–906.
  32. Koulouris S. Takotsubo cardiomyopathy: the “broken heart” syndrome. Hellenic J. Cardiol. 2010; 51: 451–457.
  33. Delaney A., Bradford C., McCaffrey J. et al. Levosimendan for the treatment of acute severe heart failure: a metaanaly sis of randomised controlled trials. Int. J. Cardiol. 2010; 138 (3): 281–289.
  34. Landoni G., Mizzi A., BiondiZoccai G. et al. Levosimendan reduces mortality in critically ill patients. A meta-analysis of randomized controlled studies. Minerva Anestesiol. 2010; 76 (4): 276–286.
  35. Westaby S., Shahir A., Sadler G. et al. Mechanical bridge to recovery in pheochromocytoma myocarditis. Nat. Rev. Cardiol. 2009; 6 (7): 482–487.



Abstract - 1857

PDF (Russian) - 618



Copyright (c) 2013 ., ., ., ., ., .

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies